Aditx Therapeutics
Aditxt is developing technologies focused on improving the immune system's health through immune monitoring and reprogramming. Aditxt's immune monitoring technology is designed to provide a personalized, comprehensive immune system profile. Aditxt's immune reprogramming technology is currently at the pre-clinical stage. It is designed to retrain the immune system to induce tolerance to address rejection of transplanted organs, autoimmune diseases, and allergies.
Last updated on
About Aditx Therapeutics
Founded
2017Estimated Revenue
$10M-$50MEmployees
11-50Funding / Mkt. Cap
$42MCategory
Sector
Health CareIndustry Group
Pharmaceuticals, Biotechnology & Life SciencesIndustry
BiotechnologyLocation
City
RichmondState
VirginiaCountry
United StatesAditx Therapeutics
Find your buyer within Aditx Therapeutics